Abstract:Background The X-linked inhibitor of apoptosis protein (XIAP) is a well-known potent apoptosis suppressor and also participates in cancer cell biological behaviors, therefore attracting great attentions as a potential antineoplastic therapeutic target for past years. Anti-IAP therapy is reported to be closely related to epidermal growth factor receptor (EGFR) expression level. However, whether and how XIAP modulates EGFR expression remains largely unknown. Methods Human XIAP was knockdown with short-hairpin RNA in two different bladder cancer cell lines, T24T and UMUC3. Two XIAP mutants, XIAP ∆BIR (deletion of N-terminal three BIR domains) and XIAP ∆RING (deletion of C-terminal RING domain and keeping the function of BIR domains), were generated to determine which domain is involved in regulating EGFR. Results We found here that lacking of XIAP expression resulted in a remarkable suppression of EGFR expression, consequently leading to the deficiency of anchorage-independent cell growth. Further study demonstrated that BIR domain of XIAP was crucial for regulating the EGFR translation by suppressing the transcription and expression of miR-200a. Mechanistic studies indicated that BIR domain activated the protein phosphatase 2 (PP2A) activity by decreasing the phosphorylation of PP2A at Tyr307 in its catalytic subunit, PP2A-C. Such activated PP2A prevented the deviant phosphorylation and activation of MAPK kinases/MAPKs, their downstream effector c-Jun, and in turn inhibiting transcription of c-Jun-regulated the miR-200a. Conclusions Our study uncovered a novel function of BIR domain of XIAP in regulating the EGFR translation, providing significant insight into the understanding of the XIAP overexpression in the cancer development and progression, further offering a new theoretical support for using XIAP BIR domain and EGFR as targets for cancer therapy.

XIAP Facilitates Breast and Colon Carcinoma Growth Via Promotion of P62 Depletion Through Ubiquitination-Dependent Proteasomal Degradation

XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling.

MiR-23a Modulates X-linked Inhibitor of Apoptosis-Mediated Autophagy in Human Luminal Breast Cancer Cell Lines.

Autophagy Regulates Apoptosis by Targeting NOXA for Degradation.

Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy

X-linked Inhibitor of Apoptosis Protein (XIAP) Regulation of Cyclin D1 Protein Expression and Cancer Cell Anchorage-independent Growth via Its E3 Ligase-mediated Protein Phosphatase 2A/c-Jun Axis

The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization.

X-linked Inhibitor of Apoptosis Protein (XIAP) Mediates Cancer Cell Motility Via Rho GDP Dissociation Inhibitor (Rhogdi)-Dependent Regulation of the Cytoskeleton

XIAP and Ciap1 Amplifications Induce Beclin 1-Dependent Autophagy Through NFκB Activation.

Regulation of XIAP Turnover Reveals a Role for USP11 in Promotion of Tumorigenesis

XIAP BIR Domain Suppresses Mir-200A Expression and Subsequently Promotes EGFR Protein Translation and Anchorage-Independent Growth of Bladder Cancer Cell

Autophagic Regulation of P62 is Critical for Cancer Therapy

XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype.

p62/SQSTM1 synergizes with autophagy for tumor growth in vivo

X-linked inhibitor of apoptosis protein (XIAP) lacking RING domain localizes to the nuclear and promotes cancer cell anchorage-independent growth by targeting the E2F1/Cyclin E axis.

Xiap Mediates Cancer Cell Motility Via Rhogdi-Dependent Regulation Of Cytoskeleton

P62 Aggregates Mediated Caspase 8 Activation is Responsible for Progression of Ovarian Cancer

Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression

Tissue microarray analysis of X-linked inhibitor of apoptosis (XIAP) expression in breast cancer patients

Xiap Inhibits Mature Smac-Induced Apoptosis by Degrading It Through Ubiquitination in Nsclc

XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin‐mediated Rho‐GDIβ mRNA stability